Cancer survival rates low for people with serious mental illness

(Medical Xpress)—People with serious mental illness have lower cancer survival rates than the general population, according to a new study by King's College London's Institute of Psychiatry (IoP) published in BMJ Open.

The study suggests that problems arise during care, rather than being associated with late diagnosis or screening, and highlights the health inequalities faced by people with .

The study was funded by the National Institute for Health Research Biomedical Research Centre (NIHR BRC) for Mental Health at the South London and Maudsley NHS Foundation Trust and King's College London.

People with serious mental illness (SMI), including bipolar disorder, schizophrenia and schizo-affective disorder, have a life expectancy 15-20 years lower than people without mental illness. Premature mortality among people with is mainly due to poor physical health, with conditions such as or heart disease substantially more common than suicide or violence.

The new study used anonymised from the NIHR BRC's Clinical Record Interactive Search and linked them to the Thames Cancer Registry. A total of 28,477 cancer cases (including lung, breast, prostate and bowel cancer) aged 15 or over were identified. Of these, 2,206 individuals had been previously assessed or treated in secondary care, 125 for severe mental illness.

The researchers found no significant difference in how advanced the cancer was at diagnosis for people with a history of mental illness, compared to those without. However, they did find that people with had worse survival after cancer diagnosis, suggesting that the problems arise during their care, rather than being due to late screening or diagnosis.

Compared to cancer patients with no history of mental illness, people with SMI had a 74% higher risk of death over the 4-5 year follow-up period. People with depression (30% higher), dementia (66% higher) and substance use disorders (42% higher) also had worse cancer survival rates.

Dr Chin-Kuo Chang, lead author of the paper from the IoP at King's says: "We found that people with mental health disorders had worse survival rates than people with no history of mental illness, even though they were not presenting with symptoms of cancer any later than other people. This suggests there is something happening during their care, rather than the problem being late diagnosis or screening."

Professor Robert Stewart, senior author of the paper from the IoP at King's, says: "Our next step is to understand the barriers to care for people with mental health problems. There are many factors to consider, including how the symptoms of mental illness and medication may affect cancer treatment, as well as the considerable social disadvantage and stigma faced by people with severe mental illness. It is unacceptable that there is such a difference between cancer for people with mental illness and people without. We need to make sure that people with have access to the same standard, quality and range of healthcare services as everyone else."

More information: Chang, C-K. et al. 'A Cohort study on mental disorders, stage of cancer at diagnosis and subsequent survival' published in BMJ Open DOI: 10.1136/bmjopen-2013-004295

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

How a common antacid could lead to cheaper anti-cancer drugs

1 hour ago

A popular indigestion medication can increase survival in colorectal cancer, according to research published in ecancermedicalscience. But in fact, scientists have studied this for years - and a group of cancer advocates want t ...

Vaccines may make war on cancer personal

2 hours ago

In the near future, physicians may treat some cancer patients with personalized vaccines that spur their immune systems to attack malignant tumors. New research led by scientists at Washington University ...

Funding to investigate an alternative to chemotherapy

3 hours ago

Professor Simon Rule, Professor in Haematology at Plymouth University Peninsula Schools of Medicine and Dentistry and Consultant Haematologist at Plymouth Hospitals NHS Trust, has been awarded a significant grant by Cancer ...

Enzyme may be key to cancer progression in many tumors

3 hours ago

Mutations in the KRAS gene have long been known to cause cancer, and about one third of solid tumors have KRAS mutations or mutations in the KRAS pathway. KRAS promotes cancer formation not only by driving ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.